McDowell, K. and Docherty, K. F. (2022) Sodium-glucose cotransporter 2 inhibitors: the first universal treatment for heart failure? European Heart Journal: Quality of Care and Clinical Outcomes, 8(4), pp. 371-373. (doi: 10.1093/ehjqcco/qcab088) (PMID:34921601) (PMCID:PMC9170565)
![[img]](https://eprints.gla.ac.uk/style/images/fileicons/text.png) |
Text
258969.pdf - Published Version Available under License Creative Commons Attribution Non-commercial. 152kB |
Abstract
No abstract available.
| Item Type: | Articles (Editorial) |
|---|---|
| Status: | Published |
| Refereed: | Yes |
| Glasgow Author(s) Enlighten ID: | McDowell, Dr Kirsty and Docherty, Dr Kieran |
| Authors: | McDowell, K., and Docherty, K. F. |
| College/School: | College of Medical Veterinary and Life Sciences > School of Cardiovascular & Metabolic Health |
| Journal Name: | European Heart Journal: Quality of Care and Clinical Outcomes |
| Publisher: | Oxford University Press |
| ISSN: | 2058-5225 |
| ISSN (Online): | 2058-1742 |
| Published Online: | 22 November 2021 |
| Copyright Holders: | Copyright © 2021 The Authors |
| First Published: | First published in European Heart Journal: Quality of Care and Clinical Outcomes 8(4): 371-373 |
| Publisher Policy: | Reproduced under a Creative Commons License |
University Staff: Request a correction | Enlighten Editors: Update this record
Deposit and Record Details
Deposit and Record Details